|1.||Acquired Immunodeficiency Syndrome (AIDS)
|2.||HIV Infections (HIV Infection)
|1.||Pereira-Chioccola, Vera Lucia: 6 articles (11/2015 - 10/2005)|
|2.||Vidal, José E: 6 articles (09/2013 - 10/2005)|
|3.||Pereira-Chioccola, Vera L: 4 articles (09/2013 - 07/2008)|
|4.||Vidal, José Ernesto: 3 articles (11/2015 - 12/2009)|
|5.||Peregudova, A B: 3 articles (01/2014 - 01/2007)|
|6.||Hiramoto, Roberto M: 3 articles (09/2013 - 07/2008)|
|7.||Meira, Cristina S: 3 articles (09/2013 - 07/2008)|
|8.||Gava, Ricardo: 2 articles (11/2015 - 09/2013)|
|9.||Motoie, Gabriela: 2 articles (11/2015 - 09/2013)|
|10.||Menotti, Jean: 2 articles (05/2015 - 11/2003)|
|1.||Pyrimethamine (Daraprim)FDA Link
06/01/1995 - "To our knowledge, these are the first cases of childhood and adult cerebral toxoplasmosis treated successfully with HNPQ and rapid oral desensitization to pyrimethamine. "
01/01/1993 - "To assess the efficacy of pyrimethamine (Pyr) for primary prophylaxis of cerebral toxoplasmosis (CT) in HIV patients (pts), 554 pts were randomized in a double-blind, placebo-controlled trial (mean follow-up: 14 months). "
06/01/1998 - "The ANRS 005/ACTG 154 Study was a double-blind, placebo-controlled, randomized, international (French, U.S., and Spanish) multicenter trial designed to assess the effectiveness of pyrimethamine for the primary prophylaxis of cerebral toxoplasmosis (CT) in HIV-infected patients with advanced immunodeficiency. "
01/01/1993 - "[Primary prevention of cerebral toxoplasmosis in patients with HIV infection: results of a double-blind randomized trial, pyrimethamine versus placebo]."
07/01/1996 - "Pyrimethamine alone as prophylaxis for cerebral toxoplasmosis in patients with advanced HIV infection."
|2.||Sulfadiazine (Sulphadiazine)FDA Link
03/01/2012 - "This case serves to remind clinicians of the need for vigilance when treating cerebral toxoplasmosis with sulphadiazine, in order to avoid this potentially serious complication of treatment."
02/01/2004 - "Between March 1999 and June 2002, 11 patients were treated for cerebral toxoplasmosis with sulfadiazine-containing therapy. "
08/01/1999 - "Two HIV seropositive patients receiving sulfadiazine for presumed cerebral toxoplasmosis who developed an obstructive nephropathy are described. "
03/01/1998 - "[Desensitization with sulfadiazine in a patient with cerebral toxoplasmosis refractory to alternative treatment]."
03/01/2006 - "Acute obstructive kidney failure can occur during sulfadiazine treatment of cerebral toxoplasmosis in immunocompromised patients. "
|3.||Clindamycin (Cleocin)FDA LinkGeneric
11/01/1998 - "Our study provides a pharmacokinetic rationale for the clinical efficacy of clindamycin in the treatment of cerebral toxoplasmosis."
09/01/2012 - "Successful treatment of cerebral toxoplasmosis with clindamycin: a case report."
08/01/1991 - "[Clindamycin in cerebral toxoplasmosis]."
08/01/1988 - "Clindamycin in cerebral toxoplasmosis."
04/01/1988 - "Clindamycin in cerebral toxoplasmosis."
|4.||Trimetrexate (JB11)FDA Link
06/01/1993 - "The clinical efficacy of trimetrexate, a dihydrofolate reductase inhibitor with potent in vitro antitoxoplasma activity, was assessed in 9 sulfonamide-intolerant patients with AIDS and biopsy-proven cerebral toxoplasmosis. "
06/01/1993 - "Salvage trial of trimetrexate-leucovorin for the treatment of cerebral toxoplasmosis in patients with AIDS."
|5.||Trimethoprim-Sulfamethoxazole Combination (Co-Trimoxazole)FDA LinkGeneric
01/01/2011 - "We are reporting a case of cerebral toxoplasmosis presented with status epileptics and treated with cotrimoxazole. "
01/01/2011 - "Successful treatment of cerebral toxoplasmosis with cotrimoxazole."
04/01/2009 - "Cotrimoxazole for treatment of cerebral toxoplasmosis: an observational cohort study during 1994-2006."
06/01/2001 - "After the patient's intracranial toxoplasmosis had been treated with intravenous bactrim, his symptoms disappeared. "
04/20/1991 - "Cerebral toxoplasmosis and co-trimoxazole prophylaxis."
|6.||Zidovudine (Retrovir)FDA LinkGeneric
05/01/1992 - "The efficacy of AZM in preventing cerebral toxoplasmosis can therefore be safely tested in human immunodeficiency virus-infected patients concomitantly treated with zidovudine."
10/15/1988 - "[Zidovudine efficacy and tolerance in 32 patients with cerebral toxoplasmosis in the acquired immunodeficiency syndrome]."
|7.||Doxycycline (Vibramycin)FDA LinkGeneric
01/01/1995 - "Roxithromycin appears to be effective in the prevention of pulmonary pneumocystis infection and of cerebral toxoplasmosis in HIV-infected patients. "
01/01/1995 - "Prevention of Pneumocystis carinii pneumonia and of cerebral toxoplasmosis by roxithromycin in HIV-infected patients."
01/01/1995 - "Five out of 18 patients treated with pentamidine aerosol, 1/17 patients treated with pentamidine aerosol + roxithromycin and none of the 17 patients treated with roxithromycin developed cerebral toxoplasmosis (p = 0.038). "
|9.||Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA
|10.||TNFR-Fc fusion protein (etanercept)FDA Link
06/01/2002 - "Symptoms and neuroradiologic abnormality improved after treatment for cerebral toxoplasmosis. "
04/08/1995 - "Symptoms and neuroradiologic findings improved after treatment for cerebral toxoplasmosis. "
10/01/1994 - "Persistent enhancement after treatment for cerebral toxoplasmosis in patients with AIDS: predictive value for subsequent recurrence."
12/01/2013 - "In this study, we report an analysis of cerebral toxoplasmosis in a series of 170 allogeneic stem cell transplant patients during a 30-month period at our institution. "
12/01/2013 - "Cerebral toxoplasmosis is a rare but fatal complication in hematopoietic stem cell transplant patients, which mostly is caused by reactivation of latent disease. "
12/01/2013 - "Analysis of cerebral toxoplasmosis in a series of 170 allogeneic hematopoietic stem cell transplant patients."
10/01/2010 - "Another developed cerebral toxoplasmosis 6 years following his second renal transplant but did not survive despite treatment. "
12/01/2004 - "One patient suffering from cerebral toxoplasmosis died 9 months post transplant. "
01/01/1995 - "In a larger population of 48 women receiving immunosuppressive therapy after organ transplantation, not a single case of cerebral toxoplasmosis was observed during pregnancy, while in the 105 HIV-positive women in the Swiss HIV and Pregnancy study, there was only one case of cerebral toxoplasmosis during pregnancy and the puerperium (20 CD4/microliters), even though some 17% of those sampled (18/105) had CD4 levels below 200 cells/microliters on at least one occasion during pregnancy. "
|4.||Highly Active Antiretroviral Therapy (HAART)
11/01/2005 - "In the group of patients receiving highly active antiretroviral therapy, who had an average CD4 of 256 cells/mm(3) and average of viral load of 52,620 copies, 16.6% had concomitant ocular and central nervous system toxoplasmosis. "
10/01/2005 - "All patients were placed on HAART within the first 4 weeks of diagnosis of cerebral toxoplasmosis. "
10/01/2005 - "At diagnosis of cerebral toxoplasmosis, only 4 (7%) patients were on highly active antiretroviral therapy (HAART), and 6 (11%) were receiving primary cerebral toxoplasmosis prophylaxis. "
10/01/2005 - "Cerebral toxoplasmosis in HIV-positive patients in Brazil: clinical features and predictors of treatment response in the HAART era."
06/01/2004 - "He was on highly active antiretroviral therapy and on neurotoxoplasmosis secondary prophylaxis. "
|5.||Transplantation (Transplant Recipients)
12/01/2007 - "Cerebral toxoplasmosis in an allogeneic peripheral stem cell transplant recipient: case report and review of literature."
11/01/2003 - "A PCR-enzyme-linked immunosorbent assay and a real-time PCR assay were compared for diagnosis and follow-up of cerebral toxoplasmosis in a stem cell transplant recipient. "
11/01/2003 - "Comparison of PCR-enzyme-linked immunosorbent assay and real-time PCR assay for diagnosis of an unusual case of cerebral toxoplasmosis in a stem cell transplant recipient."
02/01/1999 - "We report successful treatment of cerebral toxoplasmosis in an unrelated donor marrow transplant recipient. "
02/01/1999 - "Successful treatment of cerebral toxoplasmosis in a marrow transplant recipient: contribution of a PCR test in diagnosis and early detection."